Draegerwerk AG & Co. KGaA · XETR:DRW8

Draegerwerk AG & Co. KGaA — Drägerwerk — FY2005 Earnings Presentation

34 slides from Draegerwerk AG & Co. KGaA's earnings presentation, Apr 25, 2006

  1. Slide 1: Drägerwerk AG Accounts press conference

    Drägerwerk AG Accounts press conference April 25, 2006 1 April 06

  2. Slide 2: Content

    Content 1. Dräger Group - General 2. Dräger Medical 3. Dräger Safety 4. Dräger Group - Financials 5. Appendix 2 April 06

  3. Slide 3: Dräger Group - General

    Dräger Group - General 3 April 06

  4. Slide 4: Production Facilities / Sales & Service Organizations

    Dräger Group Production Facilities / Sales & Service Organizations 10,064* 9,706 9,687 4,965 5,328 5,362 5,099 4,378 4,325 2003 2004 2005 Headcount development Germany Abroad *Headcount without outsourced service companies 2003: 9,496 4 April 06

  5. Slide 5: Added Value Statement

    Dräger Group Added Value Statement Total Operating Performance Value Added Employees 1,645.5 mn € 704.6 mn € 570.1 mn € 464,2 570,1 59,2 (10,4%) Cost of materials Employees R&D 49,6 41,0 Depreciation/ Amortization 230,0 (40,3%) Government Production + Service 427,1 26,8 Other input expenses Lenders

  6. Slide 6: Outlook

    Dräger Group Outlook Net Sales/ mn € Operating EBIT/ mn € +4-7% +5-8% 1,631 128 1,521 117 2004 2005 2006e 2004 2005 2006e 6 April 06

  7. Slide 7: Dräger Medical

    Dräger Medical »Because you care« 7 April 06

  8. Slide 8: Highlights 2005

    Dräger Medical Highlights 2005 • Again increase of both net sales and profit • Order entry (+13.5 %) double-digit above both previous year as well as market growth rate - America +28.2 % - Europe (without Germany) +18.4 % • Innovations initiative continued - High investment into the future (R&D: 79.

  9. Slide 9: Business Development 2004 / 2005

    Dräger Medical Business Development 2004 / 2005 mn € 2004 2005 +/- Order entry 1,018.5 1,156.4 +13.5% Net sales 1,023.4 1,106.4 +8.1% EBITDA (before one-off´s) 114.9 124.3 +8.2% EBIT (before one-off´s) 94.2 100.7 +6.9% EBIT margin 9.2% 9.1% Non-recurring expenses 12.3 3.4 -72.4% EBIT 81.9 97.3 +18.8

  10. Slide 10: Key Figures / Development Net Sales

    Dräger Medical Key Figures / Development 100% 100% 1,106 Net Sales 68% 1,023 65% mn € 45% 747 43% 663 18% 22% 437 492 200 226 3M 3M 6M 6M 9M 9M 12M 12M 2004 2005 2004 2005 2004 2005 2004 2005 100% 100% Operating EBIT 101 94 mn € 49% 34% 36% 49 30% 11% 12% 34 34 28 10 12 3M 3M 6M 6M 9M 9M 12M 12M 200

  11. Slide 11: Key Figures / Development

    Dräger Medical Key Figures / Development mn € 2004 2005 +/- Cashflow (operating activities) 6.8 47.8 +602.9% Net financial debt -127.6 -100.3 -21.4% Investments 25.8 25.6 -0.8% Capital Employed 566.6 623.9 +10.1% ROCE 16.6% 16.1% Net Working Capital 345.8 403.4 +16.7% Capital 624 535 567 565 572 572

  12. Slide 12: Regional Sales Split 2004 / 2005 and World Market

    Dräger Medical Regional Sales Split 2004 / 2005 and World Market Dräger Medical: Dräger Medical: World Market: Sales Split Sales Split Sales Split 2004 2005 2005 Other Other Other 6% 6% 5% Germany Asia-Pacific Germany Asia-Pacific Germany 8% 22% Asia-Pacific 12% 26% 12% 18% Europe 26% America 20% Am

  13. Slide 13: Major Activities

    Dräger Medical Major Activities • Optimization of Locations worldwide 25% 50% 75% 100% - Enhancing productivity - Optimization of the communication flow - Attractiveness for staff and customers • Improvement of Product Portfolio 25% 50% 75% 100% - Reuse of components across products - Improvement of

  14. Slide 14: Outlook

    Dräger Medical Outlook Net Sales/ mn € Operating EBIT/ mn € 1,106 +5-7% 1,023 101 +6-8% 94 2004 2005 2006e 2004 2005 2006e 14 April 06

  15. Slide 15: Dräger Safety

    Dräger Safety »Pioneering Solutions« 15 April 06

  16. Slide 16: Highlights 2005

    Dräger Safety Highlights 2005 • Again increase of net sales and profit • Growth based on volume as well as on project business • Integration of Dräger Interservices GmbH • Expanding of market position - Expansion of the worldwide sales and service network - Strong sales growth in Germany and Europe

  17. Slide 17: Business Development 2004 / 2005

    Dräger Safety Business Development 2004 / 2005 mn € 2004 2005 +/- Order entry 510.0 573.2 +12.4% Net sales 503.0 557.8 1) +10.9% EBITDA (before one-off´s) 57.5 64.3 +11.8% EBIT (before one-off´s) 40.9 47.2 2) +15.4% EBIT margin 8.1% 8.5% Non-recurring expenses 0.0 0.0 +0.0% EBIT 40.9 47.2 +15.4% Net

  18. Slide 18: Key Figures / Development Net Sales

    Dräger Safety Key Figures / Development 100% 100% 503 558* Net Sales 71% 70% mn € 48% 47% 357 391* *Incl. Interservices 241 264 23% 22% (25.4 mn €) 113 123 3M 3M 6M 6M 9M 9M 12M 12M 2004 2005 2004 2005 2004 2005 2004 2005 100% 100% 47 * Operating EBIT 68% 41 68% mn € 51% 32 * 51% 28 24 * *Incl. InTe

  19. Slide 19: Key Figures / Development

    Dräger Safety Key Figures / Development mn € 2004 2005 +/- Cashflow (operating activities) 45.8 30.6 -33.2% Net financial debt 12.2 31.3 +156.6% Investments 21.6 26.0 +20.4% Capital Employed 157.8 190.8 +20.9% ROCE 25.9% 24.7% Net Working Capital 98.7 117.5 +19.0% Capital 191 194 191 154 156 170 176

  20. Slide 20: Regional Sales Split 2004 / 2005 and World Market

    Dräger Safety Regional Sales Split 2004 / 2005 and World Market Dräger Safety: Dräger Safety: World Market: Sales Split Sales Split Sales Split 2004 2005 2005 Other Other Other 4% Asia-Pacific 3% 3% Germany Asia-Pacific Germany* Asia-Pacific 11% 12% Germany 11% 26% 16% 22% America America 17% 16% Eu

  21. Slide 21: Strategy / Action Plan

    Dräger Safety Strategy / Action Plan • Permanent optimization of the cost position of new products 25% 50% 75% 100% - Design-to-cost - Platform strategy - R&D expenses approximately 5 % of net sales 25% 50% 75% 100% • Optimization of the logistics worldwide - 3 HUB´s (Europe, USA, Asia) versus misce

  22. Slide 22: Outlook

    Dräger Safety Outlook Net Sales/ mn € Operating EBIT/ mn € +4-6% 558 +3-5% 45 * 503 41 2004 2005 2006e 2004 2005 2006e * Excl. 2.1 mn € gain out of sale Dräger InTek 22 April 06

  23. Slide 23: Dräger Group - Financials

    Dräger Group - Financials 23 April 06

  24. Slide 24: Business Development 2004 / 2005

    Dräger Group Business Development 2004 / 2005 mn € 2004 2005 +/- Order entry 1,523.3 1,695.9 +11.3% Net sales 1,520.5 1,630.8 +7.3% Gross margin 49.2% 48.1% EBIT (before one-off´s) 117.2 128.2 +9.4% EBIT margin 7.7% 7.9% Non-recurring expenses 22.3 3.4 -84.8% EBIT 94.9 124.8 +31.5% Discontinued oper

  25. Slide 25: Key Figures / Development

    Dräger Group Key Figures / Development mn € 2004 2005 +/- Cashflow (operating activities) 13.1 30.2 +130.5% Net financial debt 218.3 255.8 +17.2% Investments 57.2 60.7 +6.1% Capital Employed 796.8 885.4 +11.1% ROCE 14.7% 14.5% Net Working Capital 419.9 507.6 +20.9% Capital 857 849 885 748 800 797 80

  26. Slide 26: Net Working Capital / Capital Employed

    Dräger Group Net Working Capital (NWC)/ Capital Employed (CE) mn € NWC CE CE NWC mn € 2004 2004 2005 2005 885.4 796.8 +11% 507.6 419.9 +14% +3% Inventories Inventories Trade receivables Trade receivables Other assets +5% Other assets Non-interest-bearing liabilities Non-interest-bearing liabilities

  27. Slide 27: Cash Flow Statement 2004 / 2005

    Dräger Group Cash Flow Statement 2004 / 2005 Operating Investing Financing Change in Activities Activities Activities Cash mn € 59.1 30.2 13.1 6.6 -6.8 -0.2 -37.0 -79.0 2004 2005 27 April 06

  28. Slide 28: Total Outlook / Net Sales

    Dräger Group Total Outlook / Net Sales Dräger Medical mn € Dräger Safety +5-7% +3-5% 1,106 558 1,023 503 2004 2005 2006e 2004 2005 2006e Holding / Consolidation mn € Dräger Group 2004 2005 2006e +4-7% 1,631 -5 1,521 -33 -35/-40 28 April 06 2004 2005 2006e

  29. Slide 29: Total Outlook / Operating EBIT

    Dräger Group Total Outlook / Operating EBIT Dräger Medical mn € Dräger Safety +6-8% +4-6% 101 45 * 94 41 2004 2005 2006e 2004 2005 2006e * Excl. 2.1 mn € gain out of sale Dräger InTek Holding / Consolidation mn € Dräger Group 2004 2005 2006e +5-8% 128 117 -18 -20 -20/-25 2004 2005 2006e 29 April 06

  30. Slide 30: Appendix

    Appendix 30 April 06

  31. Slide 31: Management Drägerwerk AG

    Dräger Group Management Drägerwerk AG S. Dräger (43) Dr. W. Reim (49) Prof. Dr. A. Jugel (57) H.-O. Sulzer (59) CEO Dräger Medical Dräger Safety CFO Dräger Medical Dräger Safety Dr. W. Reim (49) R. Jaksch (52) Prof. Dr. A. Jugel (57) T. Holzgreve (49) CEO CFO CEO CFO 31 April 06

  32. Slide 32: Financial Calendar

    Dräger Group Financial Calendar 25.04.2006 - Accounts press conference, Lübeck - Analysts' meeting, Frankfurt 11.05.2006 - Q1/2006 report - Conference Call 02.06.2006 - Annual stockholders´ meeting, Lübeck 10.08.2006 - Q2/2006 report - Conference Call 14.11.2006 - Q3/2006 report - Conference Call 32

  33. Slide 33: Contact

    Dräger Group Contact Corporate Communications Investor Relations Dr. Welf Böttcher Vanina Herbst Head of Corporate Communications Investor Relations Drägerwerk Aktiengesellschaft Drägerwerk Aktiengesellschaft Moislinger Allee 53-55 Moislinger Allee 53-55 D-23542 Lübeck D-23542 Lübeck Fon +49 451 882

  34. Slide 34: Disclaimer

    Dräger Group Disclaimer Estimates: This presentation contains a number of forecasts and estimates which are based on present expectations, anticipations and predictions on the part of the Executive Board and the information it currently has. Such estimates should not be construed as a warranty that

Drägerwerk — FY2005 Earnings Presentation on 6ix